@xconomy.com 1 year ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com 1 year ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@techcrunch.com 2 years ago
With $250 million, Peter Diamandis’ new startup is all about taking stem cells from placentas